Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

HCL Tech, HDFC Bank, Britannia, Axis Bank and Cipla were among the top losers on NSE in today’s trade.

Stock market update: Stocks that hit 52-week lows on NSE in today’s trade

Indian shares started Monday's session largely in the red with benchmark 30-share BSE Sensex down 7 points to start at 61,215.80, while the broader NSE Nifty50 dipped 20 points to start trade at 18,235.70. Among stocks, HCL Tech was the top loser after a mixed set of earnings, down 4.80 percent. HDC Bank, Kotak Mahindra Bank, Cipla and NTPC were other major laggards, down up to a percent. 



#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Markets Open For Trade In The Red | Bazaar Open Exchange | CNBC TV18

Cipla got a shot in the arm with an upbeat outlook for injectables and respiratory portfolios. SPARC fired up after reporting a milestone payment. Here are all the details on both the companies.

#CNBCTV18 #BusinessNews #ShareMarketToday #Nifty #Sensex #Cipla #SPARC

CNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news. The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

For latest news and updates visit our Website: https://bit.ly/2YbpXBM
Subscribe to our Channel: https://www.youtube.com/user/CNBCTV18
Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News

Healthy Gains For Cipla & SPARC, Here's Why | Markets Today | CNBC-TV18

Orientation-cum-training programme for M. Sc. (Chemistry) students

IICT, Cipla Foundation to upskill PG students from NE

Power Grid Corporation, IOC, ONGC, ITC and Cipla were among the top Nifty gainers. JSW Steel, Divis Labs, Bharti Airtel, Sun Pharma and UltraTech Cement were the top losers.

Taking Stock | Sensex Up 329 Points, Nifty Reclaims 17,000 As IT, Oil & Gas, Realty Gain

Sun Pharma performed as top gainer surging by 3% after hitting 52-week high Rs861.50 per piece.

Nifty Pharma advances 120 pts amid volatility; Sun Pharma emerges top bull; Cipla, Gland Pharma, Lupin add to winnings

Net Sales are expected to increase by 7.6 percent Y-o-Y (up 0.7 percent Q-o-Q) to Rs 5,560.6 crore, according to Prabhudas Lilladher.

Cipla Q3 PAT May Dip 6.4% YoY To Rs 700.3 Cr: Prabhudas Lilladher

Monoclonal antibody therapy, also known as cocktail therapy, has emerged as one of the effective and reliable treatment options against COVID-19. The therapy that aims to reduce viral loads and lessen symptom severity, according to health experts, can also help cut down the hospitalisation risk by 7…

Antibody Cocktail Therapy: Dr Jaideep Gogtay, Global Chief Medical Officer, Cipla Ltd, explains how it works

The company has been selected from a list of 50 reputed companies nominated for this award.

Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award 2021 as

However, the ‘Stockholders Agreement’ dated 12 November 2018 between InvaGen, Avenue and other stockholders remains in force; and InvaGen will continue to hold shares in Avenue.

Cipla announces termination of stock purchase and merger agreement with Avenue Therapeutics

Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award

Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.

Cipla Ltd

Cipla Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stock market update: Stocks that hit 52-week lows on NSE in today’s trade

News Video

Markets Open For Trade In The Red | Bazaar Open Exchange | CNBC TV18

News Video

Healthy Gains For Cipla & SPARC, Here's Why | Markets Today | CNBC-TV18

IICT, Cipla Foundation to upskill PG students from NE

Taking Stock | Sensex Up 329 Points, Nifty Reclaims 17,000 As IT, Oil & Gas, Realty Gain

Nifty Pharma advances 120 pts amid volatility; Sun Pharma emerges top bull; Cipla, Gland Pharma, Lupin add to winnings

Cipla Q3 PAT May Dip 6.4% YoY To Rs 700.3 Cr: Prabhudas Lilladher

Antibody Cocktail Therapy: Dr Jaideep Gogtay, Global Chief Medical Officer, Cipla Ltd, explains how it works

Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award 2021 as

Cipla Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Stock market update: Stocks that hit 52-week lows on NSE in today’s trade

News Video

Markets Open For Trade In The Red | Bazaar Open Exchange | CNBC TV18

News Video

Healthy Gains For Cipla & SPARC, Here's Why | Markets Today | CNBC-TV18

IICT, Cipla Foundation to upskill PG students from NE

Taking Stock | Sensex Up 329 Points, Nifty Reclaims 17,000 As IT, Oil & Gas, Realty Gain

Nifty Pharma advances 120 pts amid volatility; Sun Pharma emerges top bull; Cipla, Gland Pharma, Lupin add to winnings

Cipla Q3 PAT May Dip 6.4% YoY To Rs 700.3 Cr: Prabhudas Lilladher

Antibody Cocktail Therapy: Dr Jaideep Gogtay, Global Chief Medical Officer, Cipla Ltd, explains how it works

Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award 2021 as

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock